Biofrontera (BFRI) Total Liabilities (2020 - 2025)

Biofrontera's Total Liabilities history runs 6 years deep, the most recent figure standing at $18.1 million for Q4 2025.

• On a quarterly basis, Total Liabilities rose 2.35% year-over-year to $18.1 million in Q4 2025; TTM through Dec 2025 was $18.1 million, a 2.35% increase from a year earlier, with the FY2025 full-year figure at $18.1 million, up 2.35% from the prior year.
• Total Liabilities was little changed at $18.1 million in Q4 2025 per BFRI's latest filing, from $18.0 million in the prior quarter.
• Across five years, Total Liabilities topped out at $41.9 million in Q4 2021 and bottomed at $10.7 million in Q2 2024.
• The 5-year median for Total Liabilities is $25.2 million (2023), against an average of $25.2 million.
• Across the five-year window, Total Liabilities slumped 60.73% in 2024 and surged 132.67% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $41.9 million in 2021, then slumped by 35.52% to $27.0 million in 2022, then declined by 14.32% to $23.1 million in 2023, then fell by 23.64% to $17.7 million in 2024, then climbed by 2.35% to $18.1 million in 2025.
• Per Business Quant, the three latest BFRI Total Liabilities figures stand at $18.1 million (Q4 2025), $18.0 million (Q3 2025), and $24.8 million (Q2 2025).